New Zealand markets open in 1 hour 17 minutes

BioPlus Acquisition Corp. (BIOS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.82-0.01 (-0.09%)
As of 02:54PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close10.83
Bid10.82 x 1800
Ask10.83 x 800
Day's range10.82 - 10.82
52-week range10.05 - 11.68
Avg. volume38,060
Market cap209.564M
Beta (5Y monthly)N/A
PE ratio (TTM)51.53
EPS (TTM)0.21
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est20.00
  • GlobeNewswire

    Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring

    The Avertix Guardian™ System, the first and only FDA approved implantable heart attack warning system, now available at the Heart & Rhythm Institute of Trinity, extending their commitment to redefining cardiac care in the Tampa, FL area Dr. Luis R. Annoni-Suau, MD, FACC and Dr. Carlos J. Bayron successfully performed the first two Guardian implants at the Heart and Rhythm Institute of Trinity EATONTOWN, N.J. and TRINITY, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or

  • GlobeNewswire

    Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors

    Recently served as Boston Scientific Executive Vice President and Global Chief Medical Officer Professor Meredith brings to Avertix over 35 years of cardiology experience and commitment to advancing cardiac care EATONTOWN, N.J., July 17, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), formerly known as Angel Medical Systems, Inc., a healthcare technology company commercializing the first and only FDA-approved heart attack warning system to improve long-term managemen

  • GlobeNewswire

    Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando

    AdventHealth Orlando performs their first implant of Guardian™ System, revolutionizing cardiac care in Central FloridaEATONTOWN, N.J. and ORLANDO, Fla., June 13, 2023 (GLOBE NEWSWIRE) -- Avertix Medical, Inc. (“Avertix” or the “Company”), formerly known as Angel Medical Systems, Inc., a company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks, and AdventHealth Orlando, a nationally-ranked hospital system